MedPath

Effectiveness of a 6-week Specific Rehabilitation Program on Walking Capacity in Patients with Lumbar Spinal Stenosis

Not Applicable
Recruiting
Conditions
Spinal Stenosis
Interventions
Other: Exercises and education
Other: Education alone
Registration Number
NCT05513326
Lead Sponsor
Université du Québec à Trois-Rivières
Brief Summary

The aim of this study is to determine the effectiveness of a 6-week specific rehabilitation program combining education and exercises on walking capacity in patients with LSS causing NC.

The intervention group will receive standardized education and specific exercises while the control group will only receive standardized education. The program in both groups will last for 6 weeks with 4 evaluation timepoints (baseline, week 2, week 4 and post-intervention assessment). The primary outcomes will be walking capacity measured with the Self-Paced Walking Test and the secondary outcomes will be back and leg pain intensity, LSS-related disability, self-efficacy, level of physical activity, anxiety and depression, physical activity level, gait pattern characteristics, balance, and global perceived change.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
66
Inclusion Criteria
  • being at least 50 years old
  • having a degenerative central LSS alone or in combination with other LSS types (e.g. foraminal, lateral) and/or a spondylolisthesis affecting one or multiple vertebral levels, confirmed by clinical history, physical examination and proper imaging
  • having NC associated with LSS
  • being able to speak and understand French
  • being willing to attend 3 intervention sessions per week
  • with a duration of signs and symptoms of at least 3 months
  • (7) being able to walk at least 20 meters without walking aid, but not being able to walk continuously for 30 minutes
  • being able to provide informed written consent.
Exclusion Criteria
  • congenital LSS,
  • symptomatic osteoarthritis (hip or knee) causing limited walking capacity
  • neurological disease affecting walking capacity such as Parkinson
  • uncontrolled diabetes
  • heart failure
  • intermittent claudication of vascular origin
  • impaired cognitive capacity
  • back or lower extremities surgery in the past 3 months

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intervention GroupExercises and educationIntervention group will received education and a specific rehabilitation program (exercises).
Control GroupEducation aloneControl group will received education alone.
Primary Outcome Measures
NameTimeMethod
Change from baseline in walking capacityBaseline, week 2, week 4, week 6, week 12

Walking capacity measure with the Self-Paced Walking Test (time)

Secondary Outcome Measures
NameTimeMethod
Change from baseline in leg and back pain intensityBaseline, week 2, week 4, week 6, week 12

Leg and back pain intensity will be independently assessed using a 11-point numerical rating scale (from 0 to 10 points). Higher score indicates higher pain.

Change from baseline in lower extremity physical function and balanceBaseline, week 6, week 12

Lower extremity physical function and balance measured with the Short Physical Performance Battery. Total score ranges from 0 to 12 with higher score indicating a better lower extremity physical function and balance.

Change from baseline in lumbar spinal stenosis related disabiltityBaseline, week 6, week 12

Lumbar spinal stenosis related disability is measured with the French-Canadian version of the Swiss Spinal Stenosis Questionnaire. Pain, function and satisfaction related to lumbar spinal stenosis. Pain subscale score range from 7 to 35 with higher values indicate a worst outcome, Function subscale score range from 5 to 20 with higher values indicate a worst outcome, Satisfaction subscale score range from 6 to 24 with higher values indicate a worst outcome. The total score is composed of the three subscales and range from 18 to 79.

Change from baseline in anxiety and depressionBaseline, week 6, week 12

Measured with the French-Canadian adaptation of the Hospital Anxiety and Depression Scale. Total score range from 0 to 21 with higher score indicating symptoms of anxiety and/or depression.

Change from baseline in biomechanical parameters of gaitBaseline, week 2, week 4, week 6, week 12

Spatio-temporal parameters of gait measured with wearable inertial sensors measured in % (walking phases, assymetry, variability)

Changes from baseline in self-efficacyBaseline, week 6, week 12

Measured with Self-efficacy measured with the French-Canadian Chronic Pain Self-Efficacy Scale. Each question is rated on a numerical scale (from 1 to 10). Total is calculated using the mean of the 33-items scores and ranges from 1 to 10 with a higher score indicate higher self-efficacy.

Change from baseline in physical activity levelBaseline, week 6, week 12

Physical activity level assessed with the \[Physical Activity Questionnaire for the Elderly\]. The questionnaire allows to place participants into one of the 3 categories (low, moderate or high physical activity level). Physical activity level is measured in time per day.

Patient's global impression of changechanges of the global impression of change throughout the study (baseline, week 2, week 4, week 6, week 12)

Global impression of change will be measured using a 7-point scale that ranges from 'very much improved' to 'very much worse' with 'no change' as the mid-point.

Trial Locations

Locations (1)

Université du Québec à Trois-Rivières

🇨🇦

Trois-Rivières, Quebec, Canada

© Copyright 2025. All Rights Reserved by MedPath